Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJosep Rodes-Cabau
About this trial
To assess the prevalence and severity of frailty in patients undergoing LAAC, as well as its association to peri-procedural and long-term outcomes and quality of life.
Eligibility criteria
Qualifiers
Transcatheter LAAC with any approved device
Age ≥18 years old
Disqualifiers
Unable to provide informed consent
Severe neuropsychiatric impairment
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Josep Rodes-Cabau
Lead sponsor
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Sponsor institution
Source ClinicalTrials.gov